Delay of Ejaculation Induced by SB-277011, a Selective Dopamine D3 Receptor Antagonist, in the Rat
- 1 April 2009
- journal article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 6 (4), 980-988
- https://doi.org/10.1111/j.1743-6109.2008.01173.x
Abstract
Introduction Dopamine (DA) plays a key role in different aspects of the male sexual response, including sexual motivation and arousal, penile erection, and ejaculation. The modalities of action of DA are however unclear, although the various DA receptors may differentially mediate the activity of DA in different aspects of the male sexual response. Aim To clarify the role of DA D3 receptors in the control of the male sexual response. Methods The effects of a highly selective DA D3 receptors antagonist (SB-277011; intraperitoneal) were tested in experimental paradigms exploring several aspects of the male sexual response in (i) anesthetized rats using 7-hydroxy-N,N-di-n-propylaminotetralin to induce ejaculation and (ii) conscious rats using sexual incentive motivation and mating tests. Main Outcome Measures Physiological markers of erection and emission and expulsion phases of ejaculation were measured in anesthetized rats. Behavioral parameters of sexual incentive motivation and mating tests were quantified. Results In anesthetized rats, we found that SB-277011 specifically and dose-dependently inhibited the expulsion phase of ejaculation without impairing either emission phase or erection, and this resulted in delayed ejaculation. Administration of SB-277011 had no effect on the spontaneous preference that males displayed for sexually receptive females as shown in sexual incentive motivation test. Delayed ejaculation was confirmed when male rats were administered with the highest dose of SB-277011 (10 mg/kg) in mating test, where males were free to copulate with estrous females. In addition, the refractory period following ejaculation was lengthened in rats treated with SB-277011. Conclusion As a whole, the present data demonstrate the specific and primary role of D3 receptors in the expulsion phase of ejaculation and provide preclinical evidence for the investigation of the therapeutic potential of D3 antagonism for treating premature ejaculation. Clément P, Pozzato C, Heidbreder C, Alexandre L, Giuliano F, and Melotto S. Delay of ejaculation induced by SB-277011, a selective dopamine D3 receptor antagonist, in the rat. J Sex Med **;**:**–**.This publication has 25 references indexed in Scilit:
- Impact of Premature Ejaculation: The Psychological, Quality of Life, and Sexual Relationship ConsequencesThe Journal of Sexual Medicine, 2008
- Premature Ejaculation: Current Medical Treatment and New Directions (CME)The Journal of Sexual Medicine, 2008
- Activation of D2‐like receptors induces sympathetic climactic‐like responses in male and female anaesthetised ratsBritish Journal of Pharmacology, 2006
- PD-168077, a selective dopamine D4 receptor agonist, induces penile erection when injected into the paraventricular nucleus of male ratsNeuroscience Letters, 2005
- Dopamine and serotonin: influences on male sexual behaviorPhysiology & Behavior, 2004
- Design and Synthesis of trans-N-[4-[2-(6-Cyano-1,2,3,4-tetrahydroisoquinolin-2- yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A Potent and Selective Dopamine D3 Receptor Antagonist with High Oral Bioavailability and CNS Penetration in the RatJournal of Medicinal Chemistry, 2000
- Effects of the dopamine D3 receptor ligand 7-OH-DPAT on male rat ejaculatory behaviorPharmacology Biochemistry and Behavior, 1995
- Dopamine and sexual behaviorNeuroscience & Biobehavioral Reviews, 1995
- The selective D2 dopamine receptor antagonist eticlopride counteracts the ejaculatio praecox induced by the selective D2 dopamine agonist SND 919 in the ratLife Sciences, 1994
- Role of brain monoamines in male sexual behaviorLife Sciences, 1974